Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
13.85(c) 13.58(c) 14.7(c) 14.91(c) 14.61 Last
1 019 608 904 063 1 509 355 1 229 363 963 692 Volume
+4.06% -1.95% +8.25% +1.43% -2.01% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia,... 
Surperformance© rating of Vanda Pharmaceuticals Inc.
Trading Rating : - Investor Rating :
More about the company
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 44,4 M
EBIT 2014 -63,6 M
Net income 2014 -59,0 M
Debt 2014 -
Yield 2014 -
Sales 2015 79,6 M
EBIT 2015 -56,7 M
Net income 2015 -55,7 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 11,2x
Capi. / Sales 2015 6,26x
Capitalization 498 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
04/10 VANDA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
04/09 VANDA PHARMACEUTICALS : Announces Availability of HETLIOZ™ (tasimelteon) f..
04/09 VANDA PHARMACEUTICALS : Announces Availability of HETLIOZ(TM) (tasimelteon) for ..
03/21 VANDA PHARMACEUTICALS : Entry into a Material Definitive Agreement (form 8-K)
03/18 VANDA PHARMACEUTICALS : Breakfast Round-up - 52-Weeks High Reset: NextEra Energy..
03/11 Analysts Review Releases Research Reports on Arena, Horizon Pharma, Enanta, V..
03/05 VANDA PHARMACEUTICALS INC. : Blind Adventurer, Erik Weihenmayer, Launches Nation..
02/28 VANDA PHARMACEUTICALS INC. : Blind Adventurer, Erik Weihenmayer, Launches Nation..
02/24 VANDA PHARMACEUTICALS INC. : U.S. Patents Awarded to Inventors in District of Co..
02/24 VANDA PHARMACEUTICALS INC. : Vanda Pharmaceuticals Assigned Patent
02/19 VANDA PHARMACEUTICALS INC. : The Balancing Act® airing on Lifetime Focuses on Su..
02/13 VANDA PHARMACEUTICALS INC. : FILES (8-K) Disclosing Results of Operations and Fi..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
Vanda Pharmaceuticals Inc. : Income Statement Evolution
More Financials
EPS Revisions
Vanda Pharmaceuticals Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF